Radar Telegram alerts Open Radar

Livsayis (cemdisiran) is approved by the FDA as the first and only siRNA treatment in generalized myasthenia gravis and a single treatment in a subcutaneous dose four times a year -. Company announcement - FT.com.

תרגם לעברית

Financial Times Markets · · Source

Livsayis (cemdisiran) is approved by the FDA as the first and only siRNA treatment in generalized myasthenia gravis and a single treatment in a subcutaneous dose four times a year -. Company announcement - FT.com.

More on Radar

Want to see every report in real time?

Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.

Sign up free
Share on WhatsApp Get alerts on Telegram